Home ⟩ Insights

Insights

psychedelics

7 min read • February 17, 2025

EXCLUSIVE: Ex-Rep. Kinzinger On GOP’s Internal War Over Drug Policy, Cannabis, Psychedelics – ‘Quite Likely Legal In 5-10 Years’

3 min read • February 7, 2025

Elon Musk, Who Smoked Weed On Rogan’s Podcast, Calls Federal Drug Testing A ‘Great Idea’

3 min read • January 17, 2025

Janet Yellen Inhaled But ‘It’s Been A Long Time,’ She Tells Stephen Colbert About Weed Consumption, Psychedelics In China: Video

3 min read • November 29, 2024

Yale Center Invests $600K+ On Cannabis Research Grants: These Are The Key Conditions Being Studied

3 min read • November 29, 2024

Brazil Greenlights Hemp Production, Sale: A Game-Changer For Medical Cannabis

3 min read • November 27, 2024

DEA Sets Stage For Marijuana Rescheduling With December 2 Hearing

3 min read • November 25, 2024

Instagram Suspends Pro-Cannabis Veterans Group Without Explanation, Raising Censorship Concerns

3 min read • November 22, 2024

Nebraska’s Cannabis Legalization Faces Courtroom Showdown Over Alleged Fraud

2 min read • November 21, 2024

Denmark Moves Toward Permanent Medical Cannabis Program

4 min read • November 16, 2024

Medical Cannabis And Legal Cocaine: The Unusual Permit That Puts Border Laws In Check

2 min read • November 15, 2024

Trump-Appointed Doug Collins To Lead VA: What’s Next For Cannabis and Psychedelics In Veterans’ Healthcare?

4 min read • November 12, 2024

DEA Faces Lawsuit Alleging Bias In Marijuana Rescheduling Process

Latest Headlines

3 min read • October 16, 2026

Inside Cronos’ 58% Revenue Growth: Market Share and Expansion

3 min read • October 15, 2026

DEA Cannabis Rescheduling Faces New October 21 Deadline After Judge Weighs Reopening Hearing

2 min read • October 15, 2026

Glass House Eyes European Cannabis Exports After GACP Certification

2 min read • October 15, 2026

“Curaleaf’s Revised Offer Still Does Not Reflect the Value”: Aurora Rejects $5 Hostile Bid

6 min read • October 15, 2026

Organigram Wants More Than Revenue From Germany. It Wants the Whole Margin

5 min read • October 14, 2026

The Real Cost of a Cannabis Gummy: Azuca’s CEO on Manufacturing Margins and Scale

5 min read • October 14, 2026

Cannabis Products Have to Earn Their Shelf Space. Curio Wellness Explains How

min read • October 13, 2026

Cronos Has a $1 Billion War Chest. Zuanic Sees Up to 3x Upside

5 min read • October 13, 2026

Marijuana Rescheduling Hits a New Deadline Today, With Court Fight Stretching Into 2027

4 min read • October 9, 2026

Vireo Secures $60 Million at 8.5% to Refinance Cannabis Facilities in New York and Florida

6 min read • October 9, 2026

“This Defies All Fiduciary Logic”: Curaleaf Fires Back at Aurora; Rival Deal Rumors Swirl

4 min read • October 9, 2026

Aurora Doubles German Cannabis Output, Giving Investors More to Weigh in Curaleaf Takeover

Browse By Channels

After-Hours Center

Analyst Ratings

Be Your Own Boss

Broad U.S. Equity ETFs

california cannabis

cannabis cultivation

cannabis earnings

Christopher Dillis

Congress cannabis

Earnings Misses

Emerging Market ETFs

Emerging Markets

Entrepreneurship

Federal Reserve

Financial Advisors

first quarter earnings

germany cannabis

hemp legalization

hemp regulation

IgniteIt Events

illegal cannabis farms

intoxicating hemp-derived products

Intraday Update

Macro Economic Events

Macro Notification

Market-Moving Exclusives

Movers & Shakers

Personal Finance

Pre-Market Outlook

Small Cap Analysis

Success Stories

UC Berkeley Cannabis Research Center

unlicensed cannabis

Join the Cannabis Revolution

Ready to access the most aggressive cannabis intelligence platform? Get started with IGNITE IT today.

(opens in a new tab)